The high-dose Wegovy helped patients with obesity lose an average 20.7% of their weight after 72 weeks in a phase three trial.

A major study links Wegovy to a rare form of sudden vision loss, and finds men may face three times the risk of women.

The FDA has approved a new higher-dose version of injectable semaglutide (Wegovy HD, Novo Nordisk) for both weight loss and long-term weight-loss maintenance. The higher dose, 7.2 mg, produced an ...

If you take Zepbound, a doctor or another healthcare professional will likely give you the first dose in their office. Then, they’ll show you or someone else how to inject Zepbound at home. You can ...

A single injection of a new, experimental form of self-amplifying RNA prolonged hormone synthesis for many weeks, healing the heart in pigs.

Research led by Penn Dental's Henry Daniell investigates the use of a lettuce-based, plant-encapsulated delivery platform as ...

Long-lasting treatment suppresses HIV in people with mental illness and other conditions that make it challenging to adhere to standard treatments.

However, experts said there’s limited scientific evidence that many peptides are safe and effective. Peptides are having a moment, promoted by everyone from wellness influencers and celebrities to ...

A recent small study has found that people may be able to maintain their weight loss with fewer GLP-1 injections, but this strategy may not be effective for everyone.

Susvimo is an FDA-approved eye implant for diabetic macular edema that may reduce monthly injections to just two treatments a year while maintaining vision outcomes.

Half advice show. Half survival guide. Half absurdity-fest. (Wait, how does this work again? We're not numbers people.) Each episode, we answer all your burning questions, from how to survive a public ...